SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-115557
Filing Date
2011-04-28
Accepted
2011-04-28 17:16:25
Documents
10
Period of Report
2011-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 557949
2 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 9593
3 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 9580
4 SECTION 906 CEO AND CFO CERTIFICATION dex321.htm EX-32.1 4356
  Complete submission text file 0001193125-11-115557.txt   2461945

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT vphm-20110331.xml EX-101.INS 306901
6 XBRL TAXONOMY EXTENSION SCHEMA vphm-20110331.xsd EX-101.SCH 12792
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vphm-20110331_cal.xml EX-101.CAL 38131
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vphm-20110331_def.xml EX-101.DEF 13794
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE vphm-20110331_lab.xml EX-101.LAB 143259
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vphm-20110331_pre.xml EX-101.PRE 94050
Mailing Address 730 STOCKTON DRIVE EXTON PA 19341
Business Address 730 STOCKTON DRIVE EXTON PA 19341 6104587300
VIROPHARMA INC (Filer) CIK: 0000946840 (see all company filings)

IRS No.: 232789550 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21699 | Film No.: 11789536
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1